Citadel Advisors »

Structure Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $50M 1.2M 40.76
2023-09-30 $55M 1.1M 50.42
2023-06-30 $15M 350k 41.57
2023-03-31 $8.7M 366k 23.79

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Structure Therapeutics

Wellington Management Company
venBio Select Advisor
Federated Investors
Avidity Partners Management
T. Rowe Price Associates
Henderson Group
Citadel Advisors
Casdin Capital
Logos Global Management
Sc China Holding
Deerfield Management Company
BVF
Caption Management
Franklin Resources
RA Capital Management

View all funds holding Structure Therapeutics